Hailey Atkinson
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (42.6%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Harmony Biosciences LLC at 46.5% of the total. Reporting peaked in 2024 at $8,602 and has fallen 61.9% since, to $3,280 in 2025. Among family clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 126 payments — averaging $192.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harmony Biosciences LLC$11K
- Axsome Therapeutics, Inc.$9K
- Jazz Pharmaceuticals Inc.$3K
- Avadel CNS Pharmaceuticals, LLC$164
- Eisai Inc.$70
- Merck$61
- plus $352 from 15 others
What the payments were for
- Consulting fees$8,90637%
- Speaking & faculty fees$10,33743%
- Travel & lodging$1,7877%
- Food & beverage$2,94112%
- Education$3161%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harmony Biosciences LLC | 24 | $11,285 |
| Axsome Therapeutics, Inc. | 45 | $8,890 |
| Jazz Pharmaceuticals Inc. | 30 | $3,463 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $164 |
| Eisai Inc. | 4 | $70 |
| Merck | 4 | $61 |
| Inspire Medical Systems, Inc. | 1 | $51 |
| Amgen | 1 | $32 |
| Resmed Corp | 2 | $32 |
| Sanofi-aventis U.S. LLC | 1 | $27 |
| Arbor Pharmaceuticals, Inc. | 2 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Novo Nordisk | 1 | $22 |
| Ardelyx, Inc. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Ironwood Pharmaceuticals, Inc | 1 | $19 |
| AstraZeneca | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Itamar Medical Inc | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| AbbVie | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$24,286 in reported general payments places this provider in the 95th percentile of 3,248 family providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NeuproRotigotine | 12 | $17,484 |
| Doxepin Hcl | 15 | $2,122 |
| Ropinirole Hcl | 13 | $303 |
| Eszopiclone | 32 | $223 |
| Gabapentin | 26 | $158 |
Paid to pharmacies, not to this prescriber.
Other family in Irmo
- Stefanie GunnIrmo$13K
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.